The Role of Adjuvant VaccInation After Conization for the Treatment for Cervical Dysplasia

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 site in 1 country600 target enrollmentJanuary 1, 2020

ConditionsCervical Intraepithelial Neoplasia

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cervical Intraepithelial Neoplasia
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Enrollment: 600
Locations: 1
Primary Endpoint: HPV recurrence
Status: Active, not recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions

Detailed Description

Patients treated for HPV-related disease are counseled about the potential protective role of HPV vaccination. The investigators will monitor the risk of HPV recurrence in pateints who choce to have vaccination and who did not.

Registry

clinicaltrials.gov

Start Date

January 1, 2020

End Date

January 31, 2027

Last Updated

last year

Study Type

Observational

Sex

Female